MCP
IBB icon

Mirador Capital Partners’s iShares Biotechnology ETF IBB Stock Holding History

Mirador Capital Partners’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-30,626
Closed -$3.92M – 203
2025
Q1 		$3.92M Buy
30,626
+928
+3% +$126K 0.69% 39
2024
Q4 		$3.93M Buy
29,698
+187
+0.6% +$26.3K 0.71% 36
2024
Q3 		$4.3M Sell
29,511
-175
-0.6% -$25.3K 0.77% 35
2024
Q2 		$4.07M Buy
29,686
+853
+3% +$114K 0.77% 35
2024
Q1 		$3.96M Buy
28,833
+860
+3% +$117K 0.76% 37
2023
Q4 		$3.8M Sell
27,973
-4,649
-14% -$567K 0.8% 33
2023
Q3 		$3.99M Buy
32,622
+631
+2% +$80.2K 0.91% 25
2023
Q2 		$4.06M Sell
31,991
-1,476
-4% -$192K 0.96% 28
2023
Q1 		$4.32M Sell
33,467
-2,089
-6% -$273K 1.02% 28
2022
Q4 		$4.67M Sell
35,556
-414
-1% -$53.5K 1.1% 26
2022
Q3 		$4.21M Buy
35,970
+283
+0.8% +$35.1K 1.01% 24
2022
Q2 		$4.2M Sell
35,687
-38
-0.1% -$4.51K 0.99% 26
2022
Q1 		$4.66M Buy
35,725
+1,166
+3% +$152K 0.94% 27
2021
Q4 		$5.27M Buy
34,559
+2,878
+9% +$446K 1.11% 27
2021
Q3 		$5.12M Buy
31,681
+828
+3% +$139K 1.16% 24
2021
Q2 		$5.05M Sell
30,853
-8,049
-21% -$1.24M 1.14% 27
2021
Q1 		$5.86M Buy
38,902
+2,317
+6% +$368K 1.5% 18
2020
Q4 		$5.54M Sell
36,585
-1,081
-3% -$154K 1.52% 17
2020
Q3 		$5.1M Buy
37,666
+1,512
+4% +$205K 1.59% 17
2020
Q2 		$4.94M Sell
36,154
-299
-0.8% -$38.1K 1.85% 15
2020
Q1 		$4.63M Buy
36,453
+3,404
+10% +$392K 1.93% 16
2019
Q4 		$3.98M Buy
+33,049
New +$3.69M 1.61% 17
2017
Q4 		– Sell
-3,675
Closed -$415K – 145
2017
Q3 		$415K Sell
3,675
-20,274
-85% -$2.17M 0.24% 84
2017
Q2 		$2.52M Buy
23,949
+13,728
+134% +$1.35M 1.54% 18
2017
Q1 		$999K Buy
+10,221
New +$979K 0.73% 47

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Mirador Capital Partners's IBB Position: Q2 2025 in Review

Mirador Capital Partners sold out of iShares Biotechnology ETF (IBB) in Q2 2025, closing a stake of 30,626 shares — an estimated $3.92M sold.

Mirador Capital Partners first reported a position in IBB in Q1 2017 and held it in 25 quarters. The position peaked at $5.86M in Q1 2021. 797 funds tracked by Wall St. Rank hold IBB as of Q2 2025.

  • Mirador Capital Partners reported no remaining iShares Biotechnology ETF position as of Q2 2025 after selling out during the quarter.
  • Mirador Capital Partners sold 30,626 iShares Biotechnology ETF shares in Q2 2025, an estimated $3.92M.
  • Mirador Capital Partners first reported a position in iShares Biotechnology ETF in Q1 2017 and held it in 25 quarters.
  • Mirador Capital Partners's iShares Biotechnology ETF position peaked at $5.86M in Q1 2021.
  • 797 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2025.

Based on Mirador Capital Partners's 13F filing for Q2 2025, filed 9 Jul 2025.